BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Alcohol
,
Cisplatin
,
rs2300478
,
MYC
,
T cell differentiation
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
brca2 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Mammary gland epithelial HME1 cells cultured in EGF-free medium after recovery from BRCA2-depletion
Mammary gland hTert HME1 cells with BRCA2 siRNA knockdown grown in media with EGF
Anaplastic thyroid cancer SW1736 cells overexpressing thyroid hormone receptor beta (TRB)
Explore Curated Studies Results
Literature
Most Relevant Literature
Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy…
Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic B…
Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic te…
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients …
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carrie…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fa…
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer
Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epith…
BRCA Main Home Nutritional Intervention-random Study
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ